| http://www.w3.org/ns/prov#value | - The upregulation of ??7??1 also reduced the development of the cardiomyopathy associated with this DKO. However, the transgenic ??7 transcripts were not seen in the heart and thus the cardiomyopathy is a secondary manifestation of the skeletal muscle pathology [64].
|
